Schizophrenia Research

Scope & Guideline

Advancing understanding in schizophrenia research.

Introduction

Immerse yourself in the scholarly insights of Schizophrenia Research with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0920-9964
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1988 to 2024
AbbreviationSCHIZOPHR RES / Schizophr. Res.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Schizophrenia Research' focuses on advancing the understanding of schizophrenia through multidisciplinary research. It encompasses a wide array of studies that examine the biological, psychological, and sociocultural dimensions of schizophrenia, aiming to improve diagnosis, treatment, and patient outcomes.
  1. Multidisciplinary Research:
    The journal publishes research that integrates various disciplines including neuroscience, psychology, genetics, and sociology, contributing to a holistic understanding of schizophrenia.
  2. Clinical and Translational Studies:
    It emphasizes clinical research that translates findings from basic science into practical applications, enhancing treatment strategies and patient care.
  3. Focus on Neurobiology:
    A significant portion of published articles investigates the neurobiological underpinnings of schizophrenia, including neurotransmitter systems, brain imaging studies, and genetic factors.
  4. Psychosocial Aspects:
    The journal also addresses psychosocial factors such as stigma, social support, and quality of life, recognizing their vital role in the management of schizophrenia.
  5. Innovative Treatment Approaches:
    Studies exploring novel treatment modalities, including pharmacological advancements, psychotherapeutic interventions, and lifestyle modifications are frequently featured.
  6. Longitudinal and Cohort Studies:
    The journal includes longitudinal studies that track changes over time in symptomatology and functioning, providing insights into the course of the disorder.
Recent publications in 'Schizophrenia Research' highlight several emerging trends and themes that reflect the evolving landscape of schizophrenia research. These trends indicate a growing interest in understanding the disorder from various innovative perspectives.
  1. Digital Health Interventions:
    There is an increasing focus on digital health solutions, including telemedicine and mobile health applications, aimed at improving access to care and patient monitoring.
  2. Neuroinflammation and Immunology:
    Research exploring the role of neuroinflammation and immune responses in schizophrenia is gaining traction, suggesting a potential avenue for new therapeutic targets.
  3. Cognitive and Social Functioning:
    Emerging studies emphasize the importance of cognitive and social functioning in schizophrenia, with a particular focus on interventions that enhance these areas.
  4. Personalized Medicine:
    There is a notable trend towards personalized approaches to treatment, including pharmacogenetics and tailored psychosocial interventions based on individual patient profiles.
  5. Gut-Brain Axis Research:
    The relationship between the gut microbiome and schizophrenia is becoming a prominent area of investigation, exploring how gut health may influence psychiatric symptoms.
  6. Longitudinal and Real-World Studies:
    An increase in longitudinal studies that assess real-world outcomes and long-term effects of interventions reflects a shift towards understanding the long-term trajectory of schizophrenia.

Declining or Waning

While 'Schizophrenia Research' continues to cover a broad range of topics, certain themes seem to be declining in prominence over recent years. This shift may reflect evolving research priorities or increased focus on more pressing issues in the field.
  1. Historical Perspectives:
    There has been a noticeable decrease in articles focusing on historical analyses of schizophrenia, as contemporary research increasingly prioritizes current clinical practices and emerging findings.
  2. Basic Science Without Clinical Application:
    Studies that purely focus on basic science without immediate clinical relevance are becoming less frequent, as the journal shifts towards research that can directly inform treatment and intervention.
  3. Stigma-focused Research:
    While still relevant, research specifically addressing stigma related to schizophrenia appears to be waning, possibly overshadowed by more urgent clinical and therapeutic topics.
  4. Single-discipline Studies:
    The journal is moving away from studies that solely focus on one discipline (e.g., purely psychological studies) towards more integrated, multidisciplinary approaches.
  5. Philosophical Discussions:
    There is a reduction in articles that delve deeply into philosophical discussions about schizophrenia, as the emphasis leans more towards empirical research and practical solutions.

Similar Journals

PSYCHIATRY RESEARCH

Innovating psychiatry with every groundbreaking study.
Publisher: ELSEVIER IRELAND LTDISSN: 0165-1781Frequency: 12 issues/year

PSYCHIATRY RESEARCH is a leading journal published by Elsevier Ireland Ltd, dedicated to advancing the field of psychiatry and mental health through the dissemination of rigorous research. With an impressive impact factor and categorized in the top quartile (Q1) of both Biological Psychiatry and Psychiatry and Mental Health in 2023, this journal ranks 14th in the field of Medicine _ Psychiatry and Mental Health out of 567 journals, and 4th in Neuroscience _ Biological Psychiatry out of 51, showcasing its influence and quality. Since its inception in 1979, PSYCHIATRY RESEARCH has provided a platform for innovative studies, clinical trials, and comprehensive reviews aimed at understanding the complexities of mental health disorders. Although it operates under a traditional access model, the journal remains committed to making vital research available to the academic community, ensuring that both seasoned professionals and budding researchers have access to groundbreaking findings. Positioned as a hub for psychiatric research, it caters to a diverse audience including clinicians, psychologists, and students, empowering them to contribute to the evolving landscape of mental health care.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE

Exploring Innovations in Psychiatric Research
Publisher: SAGE PUBLICATIONS INCISSN: 0091-2174Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE is a distinguished publication dedicated to advancing the understanding of psychiatric practice and mental health issues within a medical framework. Published by SAGE PUBLICATIONS INC, this journal has been a trusted source in the field since its inception, with its archives dating back to 1973. It offers a comprehensive exploration of psychiatric research, clinical studies, and theoretical advancements that seek to bridge the gap between psychiatry and general medicine. With an impact factor reflective of its quality and relevance, categorized in the Q3 quartile in Psychiatry and Mental Health, this journal stands as a vital resource for researchers, clinicians, and students alike. Although operating on a traditional subscription model, the extensive knowledge shared within its pages contributes significantly to ongoing discussions in psychiatric and mental health education and practice. As the field continually evolves, the INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE remains committed to fostering innovative and impactful scholarship that resonates with professionals navigating the complexities of mental health in clinical contexts.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Pioneering Research in Neuropsychiatric Disorders
Publisher: AMER PSYCHIATRIC PUBLISHING, INCISSN: 0895-0172Frequency: 4 issues/year

The JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, published by AMER PSYCHIATRIC PUBLISHING, INC, stands as a pivotal resource in the interdisciplinary fields of psychiatry, neurology, and mental health. With a history spanning from 1989 to 2024, this esteemed journal, identified by the ISSN 0895-0172 and E-ISSN 1545-7222, provides a platform for cutting-edge research and clinical insights into neuropsychiatric disorders. As of 2023, the journal is recognized in Q2 quartiles for Medicine (miscellaneous), Neurology (clinical), and Psychiatry and Mental Health, showcasing its significant impact within these domains, as evidenced by its Scopus rankings placing it in the 67th and 65th percentiles respectively. The journal emphasizes the importance of advancing knowledge through empirical studies, case reports, and reviews, making it an invaluable asset for researchers, clinicians, and students dedicated to understanding the complexities of the human brain and its psychological manifestations. Although the journal does not currently offer open access, it remains essential for those seeking to stay at the forefront of neuropsychiatric advancements.

JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Bridging Research and Practice in Psychiatry and Neuroscience
Publisher: CMA-CANADIAN MEDICAL ASSOCISSN: 1180-4882Frequency: 6 issues/year

JOURNAL OF PSYCHIATRY & NEUROSCIENCE, published by the CMA-Canadian Medical Association, serves as a pivotal platform for disseminating cutting-edge research in the fields of psychiatry and neuroscience. This esteemed journal, indexed with the ISSN 1180-4882 and E-ISSN 1488-2434, focuses on advancing our understanding of mental health through meticulous peer-reviewed articles, reviews, and clinical studies. With an impressive impact within the research community, it has achieved notable rankings, including Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health, as well as Q2 in Biological Psychiatry as of 2023. The journal fosters critical dialogue among scholars and practitioners by offering insights into the complexities of brain function and mental disorders, making it a fundamental resource for healthcare professionals, researchers, and students alike. Although it operates under a subscription model, its rich content continues to inform and influence the advancement of mental health science, affirming its role in bridging the gap between research and clinical practice.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Elevating Scholarly Dialogue in Mental Health Sciences
Publisher: SPRINGER HEIDELBERGISSN: 0940-1334Frequency: 6 issues/year

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.

MOLECULAR PSYCHIATRY

Advancing the Frontiers of Mental Health Research
Publisher: SPRINGERNATUREISSN: 1359-4184Frequency: 12 issues/year

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

Alpha Psychiatry

Innovative Insights into Psychiatric Disorders and Treatments.
Publisher: AVESISSN: Frequency: 6 issues/year

Alpha Psychiatry, published by AVES, stands at the forefront of mental health research and psychiatric advancements. With a commitment to disseminating high-quality and impactful studies, this journal serves as a critical platform for scholars, clinicians, and students interested in exploring the complexities of psychiatric disorders and treatment methodologies. Although the impact factor and specific scope details are still evolving, Alpha Psychiatry is dedicated to fostering interdisciplinary dialogue and promoting innovative research that tackles contemporary challenges in the field of psychiatry. As an open-access journal, it ensures that research is widely accessible, enhancing knowledge transfer and collaboration within the global scientific community. Located in Istanbul, Turkiye, the journal proudly represents a rich academic tradition, aiming to contribute significantly to the global discourse on mental health.

Biological Psychiatry

Elevating the dialogue on mental health through innovative biological research.
Publisher: ELSEVIER SCIENCE INCISSN: 0006-3223Frequency: 24 issues/year

Biological Psychiatry is a premier journal dedicated to advancing the understanding of the biological underpinnings of psychiatric disorders. Published by Elsevier Science Inc, this esteemed journal is recognized globally for its rigorous peer-reviewed research and contributes significantly to the field of biological psychiatry. With an impressive impact factor that places it in Q1 of its category and ranks 3rd out of 51 in Neuroscience Biological Psychiatry, it reflects the journal's strength in disseminating high-quality findings that push the boundaries of knowledge. Since its inception in 1969, the journal has undergone continuous evolution, aiming to integrate biological and clinical perspectives to optimize the understanding of mental health conditions. Although it does not offer open access, Biological Psychiatry serves as a critical resource for researchers, practitioners, and students, offering insights that influence both theoretical frameworks and practical applications in the realm of psychiatric science.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging

Bridging Biological Psychiatry and Cognitive Neuroscience
Publisher: ELSEVIERISSN: 2451-9022Frequency: 12 issues/year

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Transforming Psychiatry through Interdisciplinary Research.
Publisher: TAYLOR & FRANCIS LTDISSN: 1562-2975Frequency: 8 issues/year

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, a premier academic journal published by TAYLOR & FRANCIS LTD, stands at the forefront of interdisciplinary research in the fields of Biological Psychiatry, Psychiatry, and Mental Health. Based in the United Kingdom, this esteemed journal (ISSN: 1562-2975; E-ISSN: 1814-1412) has become increasingly influential since its inception in 2000, with a remarkable impact factor that reflects its high-quality research contributions. The journal is consistently ranked in the Q1 and Q2 categories across various relevant indices, demonstrating its reputation for excellence within the academic community. With Scopus rankings placing it in the top 20th percentile for Psychiatry and Mental Health, the WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY serves as a vital resource for researchers, professionals, and students seeking to further their understanding of the intricate relationship between biological processes and psychiatric phenomena. Despite being a traditional access journal, it possesses a robust scope that encompasses groundbreaking studies, reviews, and advancements in the understanding of mental health disorders, underlining its importance as a key reference in the advancement of psychiatric science and therapeutic practices.